The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.
Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.
A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
A taurine-derived metabolite may hold the key to regulating food intake and body weight, potentially inspiring a new class of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback